Irish biomaterials company sold to Ashland for $12m

An Irish company that develops biomaterial solutions for the pharma and medical devices sector has been sold for $12 million to global chemical company Ashland.

Vornia produces a range of medical biomaterials for the pharmaceutical, cosmetic and medical devices industry, as well as for academic and industrial clients. Biomaterials are biological or synthetic substances which can be introduced into body tissue. Vornia’s biomaterial platform technologies can be applied in 3D bioprinting, drug and ...